Ubs Asset Management Americas Inc Taro Pharmaceutical Industries LTD Transaction History

Ubs Asset Management Americas Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$40.97 - $43.33 $210,176 - $222,282	5,130 Added 79.04%	11,620 $491,000
Q4 2023 Feb 14, 2024	BUY	$32.77 - $42.31 $32,638 - $42,140	996 Added 18.13%	6,490 $271,000
Q3 2023 Nov 13, 2023	BUY	$35.46 - $40.13 $194,817 - $220,474	5,494 New	5,494 $207,000
Q1 2022 May 16, 2022	SELL	$43.12 - $50.3 $365,786 - $426,694	-8,483 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$47.6 - $65.0 $26,132 - $35,685	-549 Reduced 6.08%	8,483 $0
Q3 2021 Nov 15, 2021	BUY	$62.34 - $73.38 $389,063 - $457,964	6,241 Added 223.61%	9,032 $0
Q2 2021 Aug 16, 2021	SELL	$70.26 - $76.64 $151,691 - $165,465	-2,159 Reduced 43.62%	2,791 $0
Q1 2021 May 14, 2021	BUY	$70.48 - $79.95 $67,167 - $76,192	953 Added 23.84%	4,950 $0
Q4 2020 Mar 01, 2021	BUY	$54.4 - $73.42 $217,436 - $293,459	3,997 New	3,997 $0
Q4 2017 Feb 09, 2018	SELL	$104.5 - $126.38 $2.02 Million - $2.44 Million	-19,330 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$97.26 - $116.2 $1.88 Million - $2.25 Million	19,330	19,330 $0

17K

Ticker TARO
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 37,584,600
Description
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

Stay updated on Ubs Asset Management Americas Inc with notifications on news.